Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
ARE 
Alexandria Real Estate Equities Inc (ARE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/16/2025: ARE (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
13 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Year Target Price $97.31
Year Target Price $97.31
| 3 | Strong Buy |
| 1 | Buy |
| 9 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.93% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/16/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.69B USD | Price to earnings Ratio 96.54 | 1Y Target Price 97.31 |
Price to earnings Ratio 96.54 | 1Y Target Price 97.31 | ||
Volume (30-day avg) 13 | Beta 1.27 | 52 Weeks Range 66.16 - 123.00 | Updated Date 06/30/2025 |
52 Weeks Range 66.16 - 123.00 | Updated Date 06/30/2025 | ||
Dividends yield (FY) 7.20% | Basic EPS (TTM) 0.76 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.61% | Operating Margin (TTM) 20.92% |
Management Effectiveness
Return on Assets (TTM) 1.3% | Return on Equity (TTM) 1.48% |
Valuation
Trailing PE 96.54 | Forward PE 16.69 | Enterprise Value 25678009685 | Price to Sales(TTM) 4.08 |
Enterprise Value 25678009685 | Price to Sales(TTM) 4.08 | ||
Enterprise Value to Revenue 8.45 | Enterprise Value to EBITDA 14.4 | Shares Outstanding 172988992 | Shares Floating 154108868 |
Shares Outstanding 172988992 | Shares Floating 154108868 | ||
Percent Insiders 0.99 | Percent Institutions 97.92 |
Analyst Ratings
Rating 4 | Target Price 97.31 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 9 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Alexandria Real Estate Equities Inc
Company Overview
History and Background
Alexandria Real Estate Equities, Inc. was founded in 1994. It pioneered the life science real estate niche, focusing on clustering premier science and technology campuses. Over time, it has evolved into a leading REIT for the life science, agtech, and technology industries, expanding its geographic footprint and service offerings.
Core Business Areas
- Leasing: Leasing of life science, agtech, and technology properties to tenants.
- Development: Development and redevelopment of laboratory and office space.
- Property Management: Management of properties.
Leadership and Structure
The company is led by Joel S. Marcus, Executive Chairman and Founder. The organizational structure consists of various departments, including real estate operations, development, finance, and legal.
Top Products and Market Share
Key Offerings
- Lab Space: Provision of high-quality lab space customized to tenant needs. Market share information is not publicly available in aggregate form, but Alexandria is a leading provider. Competitors include Boston Properties and BioMed Realty Trust (private).
- Office Space: Provision of office space catering to life science, agtech, and technology companies. Market share information is not publicly available in aggregate form, but Alexandria is a leading provider. Competitors include Boston Properties and BioMed Realty Trust (private).
- Agtech Facilities: Specialized facilities for agricultural technology companies. Market share information is not publicly available in aggregate form, but Alexandria is a leading provider. Competitors include Boston Properties and BioMed Realty Trust (private).
Market Dynamics
Industry Overview
The life science real estate industry is driven by strong demand for research and development space, fueled by funding for biotechnology and pharmaceutical companies. The agtech and tech real estate segments are also undergoing growth and new innovations.
Positioning
Alexandria is a market leader specializing in life science, agtech, and technology real estate. Its competitive advantages include its deep industry expertise, long-term tenant relationships, and strategic locations.
Total Addressable Market (TAM)
The TAM for life science, agtech, and tech real estate is substantial and growing. Alexandria is well positioned to capture a significant portion of this market due to its specialized focus and premier portfolio. Total TAM estimates range from $100B to $150B based on market analysis and growth projections.
Upturn SWOT Analysis
Strengths
- Specialized expertise in life science, agtech, and tech real estate
- High-quality portfolio of properties
- Strong tenant relationships
- Strategic locations in key innovation clusters
- Experienced management team
Weaknesses
- High concentration in specific geographic areas
- Sensitivity to fluctuations in research and development funding
- Exposure to economic downturns affecting tenant companies
- Capital intensive nature of real estate development
- Occupancy rates can fluctuate
Opportunities
- Expansion into new geographic markets
- Development of new types of specialized facilities
- Strategic partnerships with life science, agtech, and tech companies
- Growing demand for lab and office space
- Increasing government funding for research and development
Threats
- Economic downturns affecting tenant companies
- Increased competition from other REITs and developers
- Changes in government regulations affecting the life science, agtech, and tech industries
- Rising interest rates increasing borrowing costs
- Technological obsolescence of facilities
Competitors and Market Share
Key Competitors
- BXP
- ARE
- SPG
Competitive Landscape
Alexandria's competitive advantages include its specialized focus, high-quality portfolio, and strategic locations. However, it faces competition from larger, more diversified REITs.
Major Acquisitions
Serra Mesa Properties
- Year: 2021
- Acquisition Price (USD millions): 165
- Strategic Rationale: Expanding presence in San Diego, a key life science cluster.
Growth Trajectory and Initiatives
Historical Growth: Alexandria has experienced significant growth in revenue, net income, and asset value over the past decade, driven by its focus on life science, agtech, and technology real estate.
Future Projections: Analysts expect continued growth in the life science, agtech, and tech industries, which should drive demand for Alexandria's properties. Future projections should be updated with the lastest analyst reporting.
Recent Initiatives: Recent initiatives include the expansion of its portfolio through development and acquisitions, as well as investments in innovation and sustainability.
Summary
Alexandria Real Estate Equities is a strong REIT specializing in life science and technology real estate. Its focus on high-growth sectors and strategic locations drives its performance. However, it faces risks related to economic downturns and competition. The company's dividend and future growth prospects make it a compelling investment option.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Alexandria Real Estate Equities Inc. Investor Relations
- SEC Filings
- Financial News Articles
- Analyst Reports
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share data may be estimates based on available information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alexandria Real Estate Equities Inc
Exchange NYSE | Headquaters Pasadena, CA, United States | ||
IPO Launch date 1997-05-27 | CEO & Chief Investment Officer Mr. Peter M. Moglia | ||
Sector Real Estate | Industry REIT - Office | Full time employees 552 | Website https://www.are.com |
Full time employees 552 | Website https://www.are.com | ||
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2025, Alexandria has a total market capitalization of $28.8 billion and an asset base in North America that includes 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties undergoing construction. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.